system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, RESULTS. Meshes: Animals, Benzamides, Blotting, Southwestern, Blotting, Western, Cell Nucleus, Cells, Cultured, Electrophoretic Mobility Shift Assay, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Immunoenzyme Techniques, Immunoprecipitation, Luciferases, Male, Muscle, Smooth, Vascular, Phenanthrenes, Phosphorylation, Poly(ADP-ribose) Polymerase Inhibitors, Poly(ADP-ribose) Polymerases, Promoter Regions, Genetic, Protein Binding, RNA, Messenger, RNA, Small Interfering, Rats, Rats, Sprague-Dawley, Reactive Oxygen Species, Real-Time Polymerase Chain Reaction, Signal Transduction, Smad3 Protein, Trans-Activators, Transcription, Genetic, Transfection, Transforming Growth Factor beta.
user
Is poly ( ADP-ribose ) polymerase 1 indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell? Context: Transforming growth factor type-β (TGF-β)/Smad pathway plays an essential role in vascular fibrosis. Reactive oxygen species (ROS) generation also mediates TGF-β signaling-induced vascular fibrosis, suggesting that some sort of interaction exists between Smad and redox pathways. However, the underlying molecular mechanism is largely unknown. This study aims to investigate the influence of poly(ADP-ribose) polymerase 1 (PARP1), a downstream effector of ROS, on TGF-β signaling transduction through Smad3 pathway in rat vascular smooth muscle cells (VSMCs). TGF-β1 treatment promoted PARP1 activation through induction of ROS generation in rat VSMCs. TGF-β1-induced phosphorylation and nuclear accumulation of Smad3 was prevented by treatment of cells with PARP inhibitor, 3-aminobenzamide (3AB) or N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-2-(N,N-dimethylamino)acetami (PJ34), or PARP1 siRNA. TGF-β1 treatment promoted poly(ADP-ribosy)lation of Smad3 via activation of PARP1 in the nucleus. Poly(ADP-ribosy)lation enhanced Smad-Smad binding element (SBE) complex formation in nuclear extracts and increased DNA binding activity of Smad3. Pretreatment with 3AB, PJ34, or PARP1 siRNA prevented TGF-β1-induced Smad3 transactivation and expression of Smad3 target genes, including collagen Iα1, collagen IIIα1 and tissue inhibitor of metalloproteinase 1, in rat VSMCs.
assistant
PARP1 is indispensable for TGF-β1 induced Smad3 activation in rat VSMCs. Targeting PARP1 may be a promising therapeutic approach against vascular diseases induced by dysregulation of TGF-β/Smad3 pathway. Final Decision: yes